Medical Care

Global Point of Care & Rapid Diagnostics Market Research Report 2025

The global market for Point of Care & Rapid Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Point of Care & Rapid Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care & Rapid Diagnostics.
The Point of Care & Rapid Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Point of Care & Rapid Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care & Rapid Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson and Johnson
Thermo Fisher Scientific
Bio-Techne
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
BD
Sysmex
Cardinal Health
Quidel
GE Healthcare
EKF Diagnostics
bioMérieux SA
Accubiotech
PTS Diagnostics
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
Segment by Type
Rapid Test
Molecular Diagnostics
Segment by Application
Hospital
Home Care
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point of Care & Rapid Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care & Rapid Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Rapid Test
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global Point of Care & Rapid Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Home Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care & Rapid Diagnostics Market Perspective (2020-2031)
2.2 Global Point of Care & Rapid Diagnostics Growth Trends by Region
2.2.1 Global Point of Care & Rapid Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Point of Care & Rapid Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Point of Care & Rapid Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Point of Care & Rapid Diagnostics Market Dynamics
2.3.1 Point of Care & Rapid Diagnostics Industry Trends
2.3.2 Point of Care & Rapid Diagnostics Market Drivers
2.3.3 Point of Care & Rapid Diagnostics Market Challenges
2.3.4 Point of Care & Rapid Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue
3.1.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Point of Care & Rapid Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Point of Care & Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Point of Care & Rapid Diagnostics Revenue
3.4 Global Point of Care & Rapid Diagnostics Market Concentration Ratio
3.4.1 Global Point of Care & Rapid Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care & Rapid Diagnostics Revenue in 2024
3.5 Global Key Players of Point of Care & Rapid Diagnostics Head office and Area Served
3.6 Global Key Players of Point of Care & Rapid Diagnostics, Product and Application
3.7 Global Key Players of Point of Care & Rapid Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care & Rapid Diagnostics Breakdown Data by Type
4.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Type (2026-2031)
5 Point of Care & Rapid Diagnostics Breakdown Data by Application
5.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Point of Care & Rapid Diagnostics Market Size (2020-2031)
6.2 North America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Point of Care & Rapid Diagnostics Market Size by Country (2020-2025)
6.4 North America Point of Care & Rapid Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care & Rapid Diagnostics Market Size (2020-2031)
7.2 Europe Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Point of Care & Rapid Diagnostics Market Size by Country (2020-2025)
7.4 Europe Point of Care & Rapid Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care & Rapid Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Point of Care & Rapid Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care & Rapid Diagnostics Market Size (2020-2031)
9.2 Latin America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care & Rapid Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Point of Care & Rapid Diagnostics Introduction
11.1.4 Johnson and Johnson Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.1.5 Johnson and Johnson Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Techne
11.3.1 Bio-Techne Company Details
11.3.2 Bio-Techne Business Overview
11.3.3 Bio-Techne Point of Care & Rapid Diagnostics Introduction
11.3.4 Bio-Techne Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.3.5 Bio-Techne Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Details
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Point of Care & Rapid Diagnostics Introduction
11.4.4 Roche Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.4.5 Roche Diagnostics Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Details
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Point of Care & Rapid Diagnostics Introduction
11.5.4 Siemens Healthineers Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.5.5 Siemens Healthineers Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Details
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Point of Care & Rapid Diagnostics Introduction
11.6.4 Abbott Laboratories Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.6.5 Abbott Laboratories Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Details
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Point of Care & Rapid Diagnostics Introduction
11.7.4 Danaher Corporation Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.7.5 Danaher Corporation Recent Development
11.8 BD
11.8.1 BD Company Details
11.8.2 BD Business Overview
11.8.3 BD Point of Care & Rapid Diagnostics Introduction
11.8.4 BD Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.8.5 BD Recent Development
11.9 Sysmex
11.9.1 Sysmex Company Details
11.9.2 Sysmex Business Overview
11.9.3 Sysmex Point of Care & Rapid Diagnostics Introduction
11.9.4 Sysmex Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.9.5 Sysmex Recent Development
11.10 Cardinal Health
11.10.1 Cardinal Health Company Details
11.10.2 Cardinal Health Business Overview
11.10.3 Cardinal Health Point of Care & Rapid Diagnostics Introduction
11.10.4 Cardinal Health Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.10.5 Cardinal Health Recent Development
11.11 Quidel
11.11.1 Quidel Company Details
11.11.2 Quidel Business Overview
11.11.3 Quidel Point of Care & Rapid Diagnostics Introduction
11.11.4 Quidel Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.11.5 Quidel Recent Development
11.12 GE Healthcare
11.12.1 GE Healthcare Company Details
11.12.2 GE Healthcare Business Overview
11.12.3 GE Healthcare Point of Care & Rapid Diagnostics Introduction
11.12.4 GE Healthcare Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.12.5 GE Healthcare Recent Development
11.13 EKF Diagnostics
11.13.1 EKF Diagnostics Company Details
11.13.2 EKF Diagnostics Business Overview
11.13.3 EKF Diagnostics Point of Care & Rapid Diagnostics Introduction
11.13.4 EKF Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.13.5 EKF Diagnostics Recent Development
11.14 bioMérieux SA
11.14.1 bioMérieux SA Company Details
11.14.2 bioMérieux SA Business Overview
11.14.3 bioMérieux SA Point of Care & Rapid Diagnostics Introduction
11.14.4 bioMérieux SA Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.14.5 bioMérieux SA Recent Development
11.15 Accubiotech
11.15.1 Accubiotech Company Details
11.15.2 Accubiotech Business Overview
11.15.3 Accubiotech Point of Care & Rapid Diagnostics Introduction
11.15.4 Accubiotech Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.15.5 Accubiotech Recent Development
11.16 PTS Diagnostics
11.16.1 PTS Diagnostics Company Details
11.16.2 PTS Diagnostics Business Overview
11.16.3 PTS Diagnostics Point of Care & Rapid Diagnostics Introduction
11.16.4 PTS Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.16.5 PTS Diagnostics Recent Development
11.17 Chembio Diagnostics
11.17.1 Chembio Diagnostics Company Details
11.17.2 Chembio Diagnostics Business Overview
11.17.3 Chembio Diagnostics Point of Care & Rapid Diagnostics Introduction
11.17.4 Chembio Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.17.5 Chembio Diagnostics Recent Development
11.18 Trinity Biotech
11.18.1 Trinity Biotech Company Details
11.18.2 Trinity Biotech Business Overview
11.18.3 Trinity Biotech Point of Care & Rapid Diagnostics Introduction
11.18.4 Trinity Biotech Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.18.5 Trinity Biotech Recent Development
11.19 Sekisui Diagnostics
11.19.1 Sekisui Diagnostics Company Details
11.19.2 Sekisui Diagnostics Business Overview
11.19.3 Sekisui Diagnostics Point of Care & Rapid Diagnostics Introduction
11.19.4 Sekisui Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2020-2025)
11.19.5 Sekisui Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Point of Care & Rapid Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Rapid Test
Table 3. Key Players of Molecular Diagnostics
Table 4. Global Point of Care & Rapid Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Point of Care & Rapid Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Point of Care & Rapid Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Point of Care & Rapid Diagnostics Market Share by Region (2020-2025)
Table 8. Global Point of Care & Rapid Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Point of Care & Rapid Diagnostics Market Share by Region (2026-2031)
Table 10. Point of Care & Rapid Diagnostics Market Trends
Table 11. Point of Care & Rapid Diagnostics Market Drivers
Table 12. Point of Care & Rapid Diagnostics Market Challenges
Table 13. Point of Care & Rapid Diagnostics Market Restraints
Table 14. Global Point of Care & Rapid Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Point of Care & Rapid Diagnostics Market Share by Players (2020-2025)
Table 16. Global Top Point of Care & Rapid Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care & Rapid Diagnostics as of 2024)
Table 17. Ranking of Global Top Point of Care & Rapid Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Point of Care & Rapid Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Point of Care & Rapid Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Point of Care & Rapid Diagnostics, Product and Application
Table 21. Global Key Players of Point of Care & Rapid Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Point of Care & Rapid Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Point of Care & Rapid Diagnostics Revenue Market Share by Type (2020-2025)
Table 25. Global Point of Care & Rapid Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Point of Care & Rapid Diagnostics Revenue Market Share by Type (2026-2031)
Table 27. Global Point of Care & Rapid Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Point of Care & Rapid Diagnostics Revenue Market Share by Application (2020-2025)
Table 29. Global Point of Care & Rapid Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Point of Care & Rapid Diagnostics Revenue Market Share by Application (2026-2031)
Table 31. North America Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Point of Care & Rapid Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Point of Care & Rapid Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Point of Care & Rapid Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Point of Care & Rapid Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Point of Care & Rapid Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Point of Care & Rapid Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Point of Care & Rapid Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Johnson and Johnson Company Details
Table 47. Johnson and Johnson Business Overview
Table 48. Johnson and Johnson Point of Care & Rapid Diagnostics Product
Table 49. Johnson and Johnson Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 50. Johnson and Johnson Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Point of Care & Rapid Diagnostics Product
Table 54. Thermo Fisher Scientific Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Bio-Techne Company Details
Table 57. Bio-Techne Business Overview
Table 58. Bio-Techne Point of Care & Rapid Diagnostics Product
Table 59. Bio-Techne Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Bio-Techne Recent Development
Table 61. Roche Diagnostics Company Details
Table 62. Roche Diagnostics Business Overview
Table 63. Roche Diagnostics Point of Care & Rapid Diagnostics Product
Table 64. Roche Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Roche Diagnostics Recent Development
Table 66. Siemens Healthineers Company Details
Table 67. Siemens Healthineers Business Overview
Table 68. Siemens Healthineers Point of Care & Rapid Diagnostics Product
Table 69. Siemens Healthineers Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Siemens Healthineers Recent Development
Table 71. Abbott Laboratories Company Details
Table 72. Abbott Laboratories Business Overview
Table 73. Abbott Laboratories Point of Care & Rapid Diagnostics Product
Table 74. Abbott Laboratories Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Abbott Laboratories Recent Development
Table 76. Danaher Corporation Company Details
Table 77. Danaher Corporation Business Overview
Table 78. Danaher Corporation Point of Care & Rapid Diagnostics Product
Table 79. Danaher Corporation Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Danaher Corporation Recent Development
Table 81. BD Company Details
Table 82. BD Business Overview
Table 83. BD Point of Care & Rapid Diagnostics Product
Table 84. BD Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 85. BD Recent Development
Table 86. Sysmex Company Details
Table 87. Sysmex Business Overview
Table 88. Sysmex Point of Care & Rapid Diagnostics Product
Table 89. Sysmex Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Sysmex Recent Development
Table 91. Cardinal Health Company Details
Table 92. Cardinal Health Business Overview
Table 93. Cardinal Health Point of Care & Rapid Diagnostics Product
Table 94. Cardinal Health Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Cardinal Health Recent Development
Table 96. Quidel Company Details
Table 97. Quidel Business Overview
Table 98. Quidel Point of Care & Rapid Diagnostics Product
Table 99. Quidel Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 100. Quidel Recent Development
Table 101. GE Healthcare Company Details
Table 102. GE Healthcare Business Overview
Table 103. GE Healthcare Point of Care & Rapid Diagnostics Product
Table 104. GE Healthcare Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 105. GE Healthcare Recent Development
Table 106. EKF Diagnostics Company Details
Table 107. EKF Diagnostics Business Overview
Table 108. EKF Diagnostics Point of Care & Rapid Diagnostics Product
Table 109. EKF Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 110. EKF Diagnostics Recent Development
Table 111. bioMérieux SA Company Details
Table 112. bioMérieux SA Business Overview
Table 113. bioMérieux SA Point of Care & Rapid Diagnostics Product
Table 114. bioMérieux SA Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 115. bioMérieux SA Recent Development
Table 116. Accubiotech Company Details
Table 117. Accubiotech Business Overview
Table 118. Accubiotech Point of Care & Rapid Diagnostics Product
Table 119. Accubiotech Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 120. Accubiotech Recent Development
Table 121. PTS Diagnostics Company Details
Table 122. PTS Diagnostics Business Overview
Table 123. PTS Diagnostics Point of Care & Rapid Diagnostics Product
Table 124. PTS Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 125. PTS Diagnostics Recent Development
Table 126. Chembio Diagnostics Company Details
Table 127. Chembio Diagnostics Business Overview
Table 128. Chembio Diagnostics Point of Care & Rapid Diagnostics Product
Table 129. Chembio Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 130. Chembio Diagnostics Recent Development
Table 131. Trinity Biotech Company Details
Table 132. Trinity Biotech Business Overview
Table 133. Trinity Biotech Point of Care & Rapid Diagnostics Product
Table 134. Trinity Biotech Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 135. Trinity Biotech Recent Development
Table 136. Sekisui Diagnostics Company Details
Table 137. Sekisui Diagnostics Business Overview
Table 138. Sekisui Diagnostics Point of Care & Rapid Diagnostics Product
Table 139. Sekisui Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2020-2025) & (US$ Million)
Table 140. Sekisui Diagnostics Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 144. Authors List of This Report


List of Figures
Figure 1. Point of Care & Rapid Diagnostics Picture
Figure 2. Global Point of Care & Rapid Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point of Care & Rapid Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Rapid Test Features
Figure 5. Molecular Diagnostics Features
Figure 6. Global Point of Care & Rapid Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Point of Care & Rapid Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Home Care Case Studies
Figure 10. Point of Care & Rapid Diagnostics Report Years Considered
Figure 11. Global Point of Care & Rapid Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Point of Care & Rapid Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Point of Care & Rapid Diagnostics Market Share by Region: 2024 VS 2031
Figure 14. Global Point of Care & Rapid Diagnostics Market Share by Players in 2024
Figure 15. Global Top Point of Care & Rapid Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care & Rapid Diagnostics as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Point of Care & Rapid Diagnostics Revenue in 2024
Figure 17. North America Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Point of Care & Rapid Diagnostics Market Share by Country (2020-2031)
Figure 19. United States Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Point of Care & Rapid Diagnostics Market Share by Country (2020-2031)
Figure 23. Germany Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Point of Care & Rapid Diagnostics Market Share by Region (2020-2031)
Figure 31. China Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Point of Care & Rapid Diagnostics Market Share by Country (2020-2031)
Figure 39. Mexico Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Point of Care & Rapid Diagnostics Market Share by Country (2020-2031)
Figure 43. Turkey Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Point of Care & Rapid Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Johnson and Johnson Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 48. Bio-Techne Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 49. Roche Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 50. Siemens Healthineers Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 51. Abbott Laboratories Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 52. Danaher Corporation Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 53. BD Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 54. Sysmex Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 55. Cardinal Health Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 56. Quidel Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 57. GE Healthcare Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 58. EKF Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 59. bioMérieux SA Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 60. Accubiotech Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 61. PTS Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 62. Chembio Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 63. Trinity Biotech Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 64. Sekisui Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies